CLB
Core Laboratories Inc.
Set alert
10.64 USD +0.24 +2.31%
10.22 Day range 10.79
9.40 52-week range 19.67
- YTD
- -33.62%
- 1 year
- -33.33%
- Open
- 10.36
- Prev close
- 10.40
- Mkt cap
- 488.21M
- Vol
- 880.17K
- Avg vol
- 595.28K
- EPS
- 0.34
- P/E
- 31.29
- Div yield
- 0.24%
More statistics
- Low
- 10.22
- High
- 10.79
- Forward P/E
- 17.18
- Beta
- 2.36
- Short ratio
- 23.15
- Inst. own
- 112.62%
- Dividend
- 0.04
- Ex-div date
- Nov 3, 2024
- Earnings
- Jan 29, 2025
- 50-d avg
- 19.56
- 200-d avg
- 18.90
- 1y target
- 19.33
Financial health
Altman Z-Score
2.71 Grey zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
7 / 9 Strong
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
B-2 / 5 overall
- DCF 3
- Return on Equity 2
- Return on Assets 3
- Debt / Equity 2
- P/E 1
- P/B 3
Valuation
P/E 23.6×
FY 2016 5y median 25.8× FY 2025
P/S 1.4×
FY 2016 5y median 1.6× FY 2025
P/B 2.8×
FY 2016 5y median 3.7× FY 2025
P/FCF 33.4×
FY 2016 5y median 44.6× FY 2025
EV/EBITDA 12.5×
FY 2016 5y median 14.6× FY 2025
EV/Sales 1.7×
FY 2016 5y median 2.0× FY 2025
FCF Yield 3.0%
FY 2016 5y median 2.2% FY 2025
Profitability
Gross Margin 17.9%
FY 2016 5y median 17.8% FY 2025
Operating Margin 9.6%
FY 2016 5y median 9.6% FY 2025
Net Margin 5.6%
FY 2016 5y median 5.6% FY 2025
ROE 11.2%
FY 2016 5y median 12.5% FY 2025
ROIC 6.8%
FY 2016 5y median 6.8% FY 2025
ROA 5.1%
FY 2016 5y median 5.1% FY 2025
Growth (YoY)
Revenue 0.5%
FY 2016 FY 2025
Operating Income -13.8%
FY 2016 FY 2025
EPS (diluted) 3.0%
FY 2016 FY 2025
Free Cash Flow -48.6%
FY 2016 FY 2025
Financial Health
Current Ratio 2.0×
FY 2016 5y median 2.1× FY 2025
Quick Ratio 1.5×
FY 2016 5y median 1.6× FY 2025
Debt / Equity 0.6×
FY 2016 5y median 1.0× FY 2025
Net Debt / EBITDA 2.0×
FY 2016 5y median 2.8× FY 2025
Interest Coverage 4.8×
FY 2016 5y median 4.7× FY 2025
Dividends
Dividend Yield 0.3%
FY 2016 5y median 0.2% FY 2025
Payout Ratio 6.3%
FY 2016 5y median 6.3% FY 2025
Annual · latest fiscal year ends 2025-12-31